NEW YORK-- Share of Questcor Pharmaceuticals Inc. climbed Tuesday after the hedge fund Deerfield Management Co. disclosed a stake in the beleaguered company. THE SPARK: Deerfield President James Flynn disclosed ownership of 3.5 million Questcor shares, or a 5.8 percent stake in the Anaheim, Calif., drugmaker.
Among the stock activity stories for Tuesday, Oct. 9, from AP Business News:. _ Shares of Questcor Pharmaceuticals Inc., which had lost 60 percent of their value in the last four weeks, recovered some lost ground Tuesday after a Jefferies& Co. analyst upgraded the biopharmaceutical company's stock.
Oct 9- Questcor Pharmaceuticals Inc:. *Says during September 2012, it shipped a total of 1,740 vials of acthar to. *Source text* Further company coverage ().
*Jefferies raises Questcor Pharmaceuticals Inc to buy from hold;. price target to $28 from $24. *Jefferies cuts Optimer Pharmaceuticals Inc price target to $16 from.
NEW YORK-- Shares of Questcor Pharmaceuticals Inc., which had lost 60 percent of their value in the last four weeks, recovered some lost ground Tuesday after a Jefferies& Co. analyst upgraded the stock. Amin raised his rating to "Buy" from "Hold" and increased his price target to $28 per share from $24.